Literature DB >> 3806791

A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.

J F Rodriguez, E Paez, M Esteban.   

Abstract

A monoclonal antibody, MAbC3, that reacts with a 14,000-molecular-weight envelope protein (14K protein) of vaccinia virus completely inhibited virus-induced cell fusion during infection. Immunoblot and immunofluorescence studies revealed that the 14K protein was synthesized at about 6 to 7 h postinfection and transported from the cytoplasm to the cell surface. Synthesis and transport of the 14K protein during infection occurred in the presence of rifampin, an inhibitor of virus maturation. One- and two-dimensional gel electrophoretic analyses demonstrated that the 14K protein forms largely trimers (42K) that are covalently linked by disulfide bonds. The facts that MAbC3 prevents virus uncoating and blocks virus-induced cell fusion but does not prevent virus attachment to cells and the 14K envelope protein forms trimers all suggest that this protein plays major role in virus penetration.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3806791      PMCID: PMC253962     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  The purification fo four strains of poxvirus.

Authors:  W K JOKLIK
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

2.  Biogenesis of vaccinia: isolation and characterization of a surface component that elicits antibody suppressing infectivity and cell-cell fusion.

Authors:  W Stern; S Dales
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

3.  Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.

Authors:  K Essani; S Dales
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

4.  The mode of entry of vaccinia virus into L cells.

Authors:  J A Armstrong; D H Metz; M R Young
Journal:  J Gen Virol       Date:  1973-12       Impact factor: 3.891

5.  Complications of smallpox vaccination, 1968.

Authors:  J M Lane; F L Ruben; J M Neff; J D Millar
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

6.  Proteolytic activation of vaccinia virus for the penetration phase of infection.

Authors:  Y Ichihashi; M Oie
Journal:  Virology       Date:  1982-01-15       Impact factor: 3.616

7.  Adsorption and penetration of the trypsinized vaccinia virion.

Authors:  Y Ichihashi; M Oie
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

8.  Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecules.

Authors:  H Shida; S Dales
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

9.  Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes.

Authors:  P M Grimley; E N Rosenblum; S J Mims; B Moss
Journal:  J Virol       Date:  1970-10       Impact factor: 5.103

10.  Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus.

Authors:  L G Payne
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

View more
  57 in total

1.  Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus.

Authors:  M I Vázquez; M Esteban
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase.

Authors:  T Betakova; E J Wolffe; B Moss
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Oligomerization of fusogenic peptides promotes membrane fusion by enhancing membrane destabilization.

Authors:  Wai Leung Lau; David S Ege; James D Lear; Daniel A Hammer; William F DeGrado
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

5.  An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse.

Authors:  P C Turner; R W Moyer
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

6.  IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress.

Authors:  J F Rodriguez; G L Smith
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

7.  Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo.

Authors:  C L Lin; C S Chung; H G Heine; W Chang
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Fine structure of the vaccinia virion determined by controlled degradation and immunolocalization.

Authors:  Nissin Moussatche; Richard C Condit
Journal:  Virology       Date:  2014-12-08       Impact factor: 3.616

9.  The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene.

Authors:  D Rodriguez; J R Rodriguez; M Esteban
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Appearance of the bona fide spiral tubule of ORF virus is dependent on an intact 10-kilodalton viral protein.

Authors:  D Spehner; S De Carlo; R Drillien; F Weiland; K Mildner; D Hanau; H-J Rziha
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.